ACRS- Aclaris Therapeutics, Inc.

Name: Aclaris Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Aclaris Therapeutics, Inc. (ACRS) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. ACRS is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Leonard Braden Michael	13.95M	$62.77M	-
Other	Kolbeck Roland Wilhelm	510.0K	$2.29M	-
COO	Davis Hugh M.	336.3K	$1.51M	-
CEO	Walker Neal	274.8K	$1.24M	-
Other	Loerop James	18.7K	$84.2K	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Oct 6, 2022	Schiff Andrew N84	Director	Sell	45,539	$16.45	$749,002.06	-3.6%	-10.4%	-63.7%
Jun 17, 2022	Schiff Andrew N84	Director	Sell	19,565	$15.14	$296,268.88	-100%	-7.8%	-34.5%
Apr 25, 2022	Walker Neal85	President And CEO	Sell	70,000	$15.15	$1,060,701.00	-1.8%	+0.5%	-41.4%
Apr 18, 2022	Monahan Joseph87	Chief Scientific Officer	Sell	30,000	$16.28	$488,298.00	-22.0%	-6.4%	-42.4%
Mar 11, 2022	Walker Neal85	President And CEO	Sell	56,303	$15.91	$896,045.35	-4.1%	-4.6%	-50.1%
Mar 10, 2022	Ruffo Frank74	Chief Financial Officer	Sell	12,823	$15.55	$199,334.82	-6.0%	-3.3%	-50.7%
Mar 10, 2022	Monahan Joseph87	Chief Scientific Officer	Sell	27,165	$15.71	$426,802.90	-16.6%	-3.3%	-50.7%
Feb 9, 2022	Monahan Joseph87	Chief Scientific Officer	Sell	383	$12.68	$4,857.13	-0.4%	-12.7%	+8.8%
Feb 9, 2022	Ruffo Frank74	Chief Financial Officer	Sell	1,388	$12.66	$17,568.47	-0.8%	-12.7%	+8.8%
Feb 9, 2022	Walker Neal85	President And CEO	Sell	3,595	$12.66	$45,513.42	-0.3%	-12.7%	+8.8%

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC